KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 189 filers reported holding KRYSTAL BIOTECH INC in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,319,036 | -1.2% | 11,371 | 0.0% | 0.01% | 0.0% |
Q2 2023 | $1,334,955 | +49.1% | 11,371 | +1.7% | 0.01% | +42.9% |
Q1 2023 | $895,150 | +1.1% | 11,181 | 0.0% | 0.01% | 0.0% |
Q4 2022 | $885,759 | +13.7% | 11,181 | 0.0% | 0.01% | 0.0% |
Q3 2022 | $779,316 | +15.6% | 11,181 | +8.9% | 0.01% | +16.7% |
Q2 2022 | $674,066 | -1.3% | 10,266 | 0.0% | 0.01% | +20.0% |
Q1 2022 | $683,100 | +46.9% | 10,266 | +54.4% | 0.01% | +25.0% |
Q4 2021 | $465,028 | +34.0% | 6,648 | 0.0% | 0.00% | +33.3% |
Q3 2021 | $347,092 | -23.2% | 6,648 | 0.0% | 0.00% | -25.0% |
Q2 2021 | $452,064 | +4.2% | 6,648 | +18.0% | 0.00% | 0.0% |
Q1 2021 | $433,966 | +28.4% | 5,633 | 0.0% | 0.00% | +33.3% |
Q4 2020 | $337,980 | +39.4% | 5,633 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $242,501 | +3.9% | 5,633 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $233,319 | +19.7% | 5,633 | +24.9% | 0.00% | 0.0% |
Q1 2020 | $194,969 | -21.9% | 4,509 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $249,708 | +59.5% | 4,509 | 0.0% | 0.00% | +50.0% |
Q3 2019 | $156,575 | – | 4,509 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 771,250 | $53,949,000 | 4.15% |
First Light Asset Management, LLC | 680,170 | $47,578,000 | 3.41% |
ACT CAPITAL MANAGEMENT, LLC | 59,000 | $4,127,000 | 2.98% |
S Squared Technology, LLC | 95,215 | $6,660,000 | 2.98% |
Redmile Group, LLC | 1,820,898 | $127,372,000 | 2.90% |
Soleus Capital Management, L.P. | 228,437 | $15,979,000 | 1.60% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 50,922 | $3,562,000 | 1.59% |
Artal Group S.A. | 700,000 | $48,965,000 | 1.33% |
SILVERARC CAPITAL MANAGEMENT, LLC | 46,670 | $3,265,000 | 1.32% |
Kynam Capital Management, LP | 34,816 | $2,435,000 | 1.30% |